Show simple item record

dc.contributor.authorMeniconi, M
dc.date.accessioned2020-06-29T09:59:46Z
dc.date.issued2018-03-15
dc.identifierPCT/US2017/050886
dc.identifierWO/2018/049296
dc.identifier.citation2018
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3788
dc.languageeng
dc.language.isoeng
dc.titleHETEROARYL INHIBITORS OF PAD4
dc.typePatent
rioxxterms.licenseref.startdate2018-03-15
rioxxterms.typeOther
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/In Silico Medicinal Chemistry
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/In Silico Medicinal Chemistry
pubs.embargo.termsNot known
icr.researchteamIn Silico Medicinal Chemistryen_US
dc.contributor.icrauthorMeniconi, Mirco


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record